Statistics for New Ref-1/APE1 targeted inhibitors demonstrating improved potency for clinical applications in multiple cancer types
Total visits
| views | |
|---|---|
| New Ref-1/APE1 targeted inhibitors demonstrating improved potency for clinical applications in multiple cancer types | 4 |
Total visits per month
| views | |
|---|---|
| December 2024 | 0 |
| January 2025 | 0 |
| February 2025 | 1 |
| March 2025 | 0 |
| April 2025 | 1 |
| May 2025 | 0 |
| June 2025 | 0 |
File Visits
| views | |
|---|---|
| java.util.UUID:e07f3e4d-3ee8-4823-923e-5b0f3cc461f5 | 39 |
| java.util.UUID:276422c5-cae7-467d-829e-f93cd6b2234c | 13 |
| java.util.UUID:a6dbd063-3ea3-49d7-bef8-22fe9b8849f3 | 6 |
| Gampala2024New-AAM.pdf | 3 |
Top country views
| views | |
|---|---|
| United States | 4 |
Top city views
| views | |
|---|---|
| Indianapolis | 3 |
| Muncie | 1 |